Does preserved pancreatic elastase with elevated stool triglycerides suggest an emulsification bottleneck?

Diagnostic role of pancreatic elastase

• A preserved fecal elastase-1 (FE-1) level (typically ≥200 µg/g) is a highly sensitive clinical marker (~0.94–0.96 sensitivity) that effectively rules out moderate-to-severe exocrine pancreatic insufficiency (EPI).
• When pancreatic elastase is normal, primary pancreatic failure is highly unlikely, directing clinical attention toward non-pancreatic drivers of lipid abnormalities.

Mechanistic pathways of emulsification failure

• Low stool phospholipids can indicate a deficiency in bile salts or bile-derived phospholipids, which are critical components for micelle formation and physical fat emulsification.
• A deficiency in these biliary lipids prevents the proper emulsification of dietary fats into mixed micelles, creating a physical bottleneck prior to enzymatic breakdown.
• Because the lipid surface area available for lipase to act upon is restricted, a portion of dietary triglycerides remains unhydrolyzed, leading to elevated stool triglycerides.

Clinical implications of isolated lipid patterns

• The combination of elevated stool triglycerides and normal total fecal fat excretion indicates that global, generalized fat malabsorption is absent.
• Rather than a severe, continuous malabsorptive disease, this specific laboratory pattern indicates a localized, meal-dependent emulsification bottleneck where the capacity to process a transient dietary fat load is temporarily exceeded.

Bottom line

• In patients with preserved pancreatic elastase, a profile of elevated stool triglycerides, low stool phospholipids, and normal total fecal fat points to a meal-dependent emulsification bottleneck—driven by biliary or micellar insufficiency—rather than global fat malabsorption.